We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0599 | -4.57251908397 | 1.31 | 1.35 | 1.14 | 22985 | 1.23665853 | CS |
4 | -0.2599 | -17.2119205298 | 1.51 | 1.7866 | 1.14 | 15504 | 1.45995942 | CS |
12 | -0.6599 | -34.5497382199 | 1.91 | 1.9799 | 1.14 | 13209 | 1.63211303 | CS |
26 | -0.6199 | -33.1497326203 | 1.87 | 2.18 | 1.14 | 11281 | 1.73317869 | CS |
52 | -1.2999 | -50.9764705882 | 2.55 | 3.2 | 1.14 | 11200 | 2.06371065 | CS |
156 | -1.9599 | -61.0560747664 | 3.21 | 4.45 | 1.14 | 14280 | 2.72934038 | CS |
260 | -1.9599 | -61.0560747664 | 3.21 | 4.45 | 1.14 | 14280 | 2.72934038 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions